References
- Ong DC, Koh TH, Syahidah N, Krishnan P, Tan TY. Rapid detection of blaNDM-1 gene by real-time PCR. J Antimicrob Chemother 2011;66:1647–9.
- Yong D, Toleman MA, Giske CG, Cho HS, Sunman K, Lee K, . Characterisation of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53: 5046–54.
- Struelens MJ, Monnel DL, Magiorakoys AP, Santos O'Connor F, Giesecke J; European NDM-1 Survey participants. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 2010;15. pii 19716.
- Kumarasamy KK, Toleman MA, Walsh TR, Bageria J, Butt F, Balakrishnan R, . Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597–602.
- Chan HL, Poon LM, Chan SG, Teo JW. The perils of medical tourism: NDM-1-positive Escherichia coli causing febrile neutropenia in a medical tourist. Singapore Med J 2011;52:299–302.
- Koh TH, Khoo CT, Wijaya L, Leong HN, Lo YL, Lim LC, . Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010;10:828.
- Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, . Clinical practise guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:e56–93.
- Wong GC, Tan BH. Use of antibiotics in a haematological ward—an audit. Ann Acad Med Singapore 2008;37: 21–6.
- Jin J, Yee ML, Ding Y, Koh LP, Lim SE, Lim R, . Prospective audit of febrile neutropenia management at a tertiary university hospital in Singapore. Ann Acad Med Singapore 2010;39:453–9.
- Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228–36.
- Peleg AY, Potoski BA, Rea R, Adams J, Sethi J, Capitano B, . Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother 2007;59:128–31.
- Neuner EA, Yeh JY, Hall GS, Sekeres J, Endimiani A, Bonomo RA, . Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis 2011;69:357–62.
- Daly MW, Riddle DJ, Ledeboer NA, Dunne WM, Ritchie DJ. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae. Pharmacotherapy 2007;27:1052–7.
- Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 2007;60:1206–15.